New York Senate Bill S03416

New York 2025-2026 Regular Session

• Introduced: 1/27/25
• Refer: 1/27/25
• Report Pass: 5/13/25
• Engrossed: 6/5/25
• Refer: 6/5/25
• Engrossed: 6/13/25
• Enrolled: 11/17/25
• Chaptered: 11/21/25
• Passed: 11/21/25

Caption

Authorizes practitioners in institutional dispensers to dispense controlled substances as emergency treatment for use off the premises of the institutional dispenser; authorizes practitioners to dispense controlled substances for use in maintenance or detoxification treatment to an addict or habitual user.

Summary

S03416 amends New York’s Public Health Law to expand when institutional dispensers and practitioners may dispense certain controlled substances in emergency situations for use off the premises of a hospital or other institutional dispenser. The bill authorizes a practitioner in a hospital without a full-time pharmacy to dispense controlled substances to a patient for up to 24 hours in an emergency, and it also adds authority for up to three days of medication for initiating maintenance treatment, withdrawal management, or both, unless federal law allows a longer period. It further allows practitioners to order and dispense, but not prescribe, methadone or another commissioner-designated controlled substance for these emergency, short-term purposes. The bill also updates older statutory language throughout Article 33 of the Public Health Law by replacing references to “addicts” and “habitual users” with “individuals with substance use disorder,” and by revising related headings and provisions to reflect current terminology. It preserves the general prohibition on prescribing or dispensing controlled substances outside the statute’s exceptions, while creating a more explicit emergency-treatment pathway tied to federal law and DEA authorization.

Impact

The bill would amend sections 3342, 3350, and 3351 of the Public Health Law and update the title heading for Title 5 of Article 33. Its practical effect is to broaden the authority of institutional dispensers and practitioners to provide limited emergency supplies of controlled substances, including methadone, for withdrawal management and maintenance treatment, while aligning state law with federal rules and terminology. Hospitals and practitioners would gain clearer authority to bridge patients through short emergency periods, and individuals with substance use disorder could receive time-limited treatment access outside the facility.

Sentiment

The bill appears to have broad legislative support and little visible opposition. It advanced unanimously in the Senate Health Committee, passed the Senate Rules Committee with only one nay, and then passed both chambers by large margins. The voting pattern suggests the measure was viewed favorably as a public health and treatment-access bill, particularly one that modernizes language and improves emergency access to medication-assisted treatment.

Contention

The main policy issue is the expansion of dispensing authority for controlled substances outside the usual prescription framework, especially for methadone and similar drugs used in maintenance or withdrawal management. Any concerns likely center on diversion, oversight, and ensuring compliance with federal DEA requirements, though the bill limits the authority to emergency situations and short durations. A secondary point of discussion is the replacement of older stigmatizing terminology with person-centered substance use disorder language, which is generally noncontroversial but reflects a broader shift in how the law describes affected individuals.